DexCom Gross Profit 2010-2024 | DXCM
DexCom annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- DexCom gross profit for the quarter ending September 30, 2024 was $0.594B, a 4.73% decline year-over-year.
- DexCom gross profit for the twelve months ending September 30, 2024 was $2.439B, a 12.21% increase year-over-year.
- DexCom annual gross profit for 2023 was $2.289B, a 21.55% increase from 2022.
- DexCom annual gross profit for 2022 was $1.883B, a 12.06% increase from 2021.
- DexCom annual gross profit for 2021 was $1.681B, a 31.28% increase from 2020.
| DexCom Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $2,289 |
| 2022 | $1,883 |
| 2021 | $1,681 |
| 2020 | $1,280 |
| 2019 | $932 |
| 2018 | $664 |
| 2017 | $492 |
| 2016 | $378 |
| 2015 | $278 |
| 2014 | $176 |
| 2013 | $100 |
| 2012 | $47 |
| 2011 | $36 |
| 2010 | $18 |
| 2009 | $4 |
| DexCom Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $594 |
| 2024-06-30 | $627 |
| 2024-03-31 | $562 |
| 2023-12-31 | $657 |
| 2023-09-30 | $623 |
| 2023-06-30 | $546 |
| 2023-03-31 | $463 |
| 2022-12-31 | $541 |
| 2022-09-30 | $494 |
| 2022-06-30 | $450 |
| 2022-03-31 | $398 |
| 2021-12-31 | $473 |
| 2021-09-30 | $447 |
| 2021-06-30 | $417 |
| 2021-03-31 | $344 |
| 2020-12-31 | $399 |
| 2020-09-30 | $340 |
| 2020-06-30 | $284 |
| 2020-03-31 | $257 |
| 2019-12-31 | $309 |
| 2019-09-30 | $247 |
| 2019-06-30 | $207 |
| 2019-03-31 | $169 |
| 2018-12-31 | $223 |
| 2018-09-30 | $169 |
| 2018-06-30 | $154 |
| 2018-03-31 | $119 |
| 2017-12-31 | $154 |
| 2017-09-30 | $127 |
| 2017-06-30 | $118 |
| 2017-03-31 | $94 |
| 2016-12-31 | $117 |
| 2016-09-30 | $101 |
| 2016-06-30 | $86 |
| 2016-03-31 | $75 |
| 2015-12-31 | $91 |
| 2015-09-30 | $75 |
| 2015-06-30 | $66 |
| 2015-03-31 | $47 |
| 2014-12-31 | $59 |
| 2014-09-30 | $47 |
| 2014-06-30 | $40 |
| 2014-03-31 | $30 |
| 2013-12-31 | $34 |
| 2013-09-30 | $28 |
| 2013-06-30 | $22 |
| 2013-03-31 | $17 |
| 2012-12-31 | $18 |
| 2012-09-30 | $8 |
| 2012-06-30 | $11 |
| 2012-03-31 | $9 |
| 2011-12-31 | $11 |
| 2011-09-30 | $8 |
| 2011-06-30 | $12 |
| 2011-03-31 | $5 |
| 2010-12-31 | $7 |
| 2010-09-30 | $3 |
| 2010-06-30 | $5 |
| 2010-03-31 | $3 |
| 2009-12-31 | $4 |
| 2009-09-30 | $1 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $30.463B | $3.622B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.584B | 24.71 |
| Intuitive Surgical (ISRG) | United States | $193.049B | 100.93 |
| Alcon (ALC) | Switzerland | $43.825B | 29.32 |
| Edwards Lifesciences (EW) | United States | $42.082B | 26.72 |
| IQVIA Holdings (IQV) | United States | $36.452B | 20.08 |
| IDEXX Laboratories (IDXX) | United States | $34.535B | 40.67 |
| Waters (WAT) | United States | $22.843B | 33.78 |
| STERIS (STE) | Ireland | $21.623B | 24.89 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.352B | 0.00 |
| Hologic (HOLX) | United States | $18.042B | 19.49 |
| Sysmex ADR (SSMXY) | Japan | $13.304B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.922B | 13.27 |
| Globus Medical (GMED) | United States | $11.657B | 29.52 |
| Penumbra (PEN) | United States | $9.369B | 91.77 |
| Masimo (MASI) | United States | $9.238B | 44.70 |
| Teleflex (TFX) | United States | $8.957B | 14.28 |
| Glaukos (GKOS) | United States | $7.920B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.988B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.713B | 26.71 |
| Veracyte (VCYT) | United States | $3.329B | 99.88 |
| Inari Medical (NARI) | United States | $3.040B | 0.00 |
| TransMedics (TMDX) | United States | $2.910B | 92.25 |
| LivaNova (LIVN) | United Kingdom | $2.851B | 16.46 |
| Nihon Kohden (NHNKY) | Japan | $2.276B | 17.29 |
| Elekta AB (EKTAY) | Sweden | $2.261B | 20.33 |
| Tandem Diabetes Care (TNDM) | United States | $2.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
| RxSight (RXST) | United States | $1.889B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.486B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.316B | 0.00 |
| Artivion (AORT) | United States | $1.237B | 82.00 |
| OPKO Health (OPK) | United States | $1.051B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.881B | 14.97 |
| Paragon 28 (FNA) | United States | $0.863B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.746B | 0.00 |
| IRadimed (IRMD) | United States | $0.683B | 36.94 |
| Mesa Laboratories (MLAB) | United States | $0.636B | 15.00 |
| OrthoPediatrics (KIDS) | United States | $0.629B | 0.00 |
| AxoGen (AXGN) | United States | $0.612B | 0.00 |
| SiBone (SIBN) | United States | $0.569B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.531B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.523B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.473B | 27.82 |
| Tactile Systems Technology (TCMD) | United States | $0.469B | 25.38 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| CVRx (CVRX) | United States | $0.372B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.341B | 0.00 |
| NeuroPace (NPCE) | United States | $0.316B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| Inogen (INGN) | United States | $0.231B | 0.00 |
| Accuray (ARAY) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.203B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.172B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.164B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.139B | 14.93 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.083B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.072B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.069B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Neuronetics (STIM) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |